Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tg Therapeutics
(NQ:
TGTX
)
23.31
-0.63 (-2.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,996,482
Open
23.97
Bid (Size)
23.31 (2)
Ask (Size)
23.50 (6)
Prev. Close
23.94
Today's Range
23.13 - 24.23
52wk Range
6.520 - 26.41
Shares Outstanding
154,420,772
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
October 15, 2024
TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
Why NASDAQ:TGTX qualifies as a high growth stock.
October 15, 2024
Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for high growth investing?
Via
Chartmill
Performance
YTD
+36.80%
+36.80%
1 Month
-7.68%
-7.68%
3 Month
+11.00%
+11.00%
6 Month
+69.16%
+69.16%
1 Year
+248.95%
+248.95%
More News
Read More
For those who appreciate growth without the sticker shock, NASDAQ:TGTX is worth considering.
October 09, 2024
Via
Chartmill
Unlocking the Growth Potential of NASDAQ:TGTX.
September 30, 2024
Via
Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Stock Market Hits Record Highs On Big Fed Rate Cut; Apple, Intel, FedEx In Focus: Weekly Review
September 20, 2024
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Evaluating TG Therapeutics: Insights From 4 Financial Analysts
September 18, 2024
Via
Benzinga
What's Going On With TG Therapeutics Stock Wednesday?
September 18, 2024
Via
Benzinga
Why NASDAQ:TGTX is Poised for High Growth.
September 09, 2024
Via
Chartmill
IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug
September 18, 2024
Via
Investor's Business Daily
Despite its growth, NASDAQ:TGTX remains within the realm of affordability.
September 18, 2024
Via
Chartmill
NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
September 16, 2024
Via
Chartmill
What's Going On With ADMA Biologics Stock Monday?
September 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
August 28, 2024
Via
Chartmill
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Decoding TG Therapeutics's Options Activity: What's the Big Picture?
August 19, 2024
Via
Benzinga
IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter
August 19, 2024
Via
Investor's Business Daily
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
Why the growth investor may take a look at NASDAQ:TGTX.
August 19, 2024
Via
Chartmill
A Closer Look at TG Therapeutics's Options Market Dynamics
August 16, 2024
Via
Benzinga
NASDAQ:TGTX: a strong growth stock preparing for the next leg up?.
August 13, 2024
Via
Chartmill
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
August 09, 2024
Via
Investor's Business Daily
NASDAQ:TGTX is showing decent growth, but is still valued reasonably.
August 07, 2024
Via
Chartmill
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
August 06, 2024
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
August 06, 2024
Via
Benzinga
Exposures
Fossil Fuels
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.